Effect of quinolinic acid on human astrocytes morphology and functions: Implications in Alzheimer's disease

Journal of Neuroinflammation

Volumn 6, Issue , 2009, Pages

  Ting, Ka K ^a,b   Brew, Bruce J ^a   Guillemin, Gilles J ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; INTERLEUKIN 1BETA; QUINOLINIC ACID; TUMOR NECROSIS FACTOR ALPHA; VIMENTIN; AMYLOID BETA PROTEIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL FUNCTION; CELL STRUCTURE; CONCENTRATION (PARAMETERS); ENZYME INHIBITION; HUMAN; HUMAN CELL; NEUROPATHOLOGY; PROTEIN EXPRESSION; RISK FACTOR; ANIMAL; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ASTROCYTES; CELL PROLIFERATION; CELLS, CULTURED; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; QUINOLINIC ACID; RATS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA; VIMENTIN;

EID: 73249145672     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-6-36     Document Type: Article

References (67)

1. Stone TW. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 1993, 45:309-379.
2. Guillemin GJ, Kerr SJ, Brew BJ. Involvement of quinolinic acid in AIDS dementia complex. Neurotox Res 2005, 7:103-123. 10.1007/BF03033781, 15639803.
3. Guillemin GJ, Brew BJ. Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease. Redox Rep 2002, 7:199-206. 10.1179/135100002125000550, 12396664.
4. Guillemin GJ, Brew BJ, Noonan CE, Knight TG, Smythe GA, Cullen KM. Mass spectrometric detection of quinolinic acid in microdissected Alzheimer's disease plaques. International Congress Series 2007, 1304:404-408. Takai K.
5. Guillemin GJ, Brew BJ, Noonan CE, Takikawa O, Cullen KM. Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus. Neuropathol Appl Neurobiol 2005, 31:395-404. 10.1111/j.1365-2990.2005.00655.x, 16008823.
6. Rahman A, Ting K, Cullen KM, Braidy N, Brew BJ, Guillemin GJ. The excitotoxin quinolinic acid induces tau phosphorylation in human neurons. PLoS ONE 2009, 4:e6344. 10.1371/journal.pone.0006344, 2709912, 19623258.
7. Pekny M, Johansson CB, Eliasson C, Stakeberg J, Wallen A, Perlmann T, Lendahl U, Betsholtz C, Berthold CH, Frisen J. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J Cell Biol 1999, 145:503-514. 10.1083/jcb.145.3.503, 2185074, 10225952.
8. Walton HS, Dodd PR. Glutamate-glutamine cycling in Alzheimer's disease. Neurochem Int 2007, 50:1052-1066. 10.1016/j.neuint.2006.10.007, 17141374.
9. Frederickson RC. Astroglia in Alzheimer's disease. Neurobiol Aging 1992, 13:239-253. 10.1016/0197-4580(92)90036-W, 1522941.
10. Streit WJ. Microglia and Alzheimer's disease pathogenesis. J Neurosci Res 2004, 77:1-8. 10.1002/jnr.20093, 15197750.
11. Heyes MP, Morrison PF. Quantification of local de novo synthesis versus blood contributions to quinolinic acid concentrations in brain and systemic tissues. J Neurochem 1997, 68:280-288.
12. Minagar A, Shapshak P, Heyes M, Sheremata WA, Fujimara R, Ownby R, Goodkin K, Eisdorfer K. Microglia and astrocytes in neuro-AIDS, alzheimers disease, and multiple sclerosis. ScientificWorldJournal 2001, 1:69.
13. Hu J, Akama KT, Krafft GA, Chromy BA, Van Eldik LJ. Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res 1998, 785:195-206. 10.1016/S0006-8993(97)01318-8, 9518610.
14. Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, Matthews F, Savva G, Brayne C, Wharton SB. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging 2008,
15. Guillemin GJ, Croitoru-Lamoury J, Dormont D, Armati PJ, Brew BJ. Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes. Glia 2003, 41:371-381. 10.1002/glia.10175, 12555204.
16. Stone TW, Behan WM. Interleukin-1beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: protection by an adenosine A2A receptor antagonist. J Neurosci Res 2007, 85:1077-1085. 10.1002/jnr.21212, 17304576.
17. Guillemin GJ, Wang L, Brew BJ. Quinolinic acid selectively induces apoptosis of human astocytes: Potential role in AIDS dementia complex. J Neuroinflammation 2005, 2:1-6. 10.1186/1742-2094-2-16, 545941, 15642121.
18. Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000, 32:1-14. 10.1002/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W, 10975906.
19. Le Prince G, Delaere P, Fages C, Lefrancois T, Touret M, Salanon M, Tardy M. Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type. Neurochem Res 1995, 20:859-862. 10.1007/BF00969698, 7477679.
20. Ting K, Brew BJ, Guillemin GJ. The involvement of astrocytes and kynurenine pathway in Alzheimer's disease. Neurotox Res 2008, 12:247-262.
21. Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ, Croitoru J, Brew BJ. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J Neurochem 2001, 78:1-13.
22. Guillemin G, Boussin FD, Croitoru J, Franck-Duchenne M, Le Grand R, Lazarini F, Dormont D. Obtention and characterization of primary astrocyte and microglial cultures from adult monkey brains. J Neurosci Res 1997, 49:576-591. 10.1002/(SICI)1097-4547(19970901)49:5<576::AID-JNR8>3.0.CO;2-8, 9302079.
23. Zeisberg M, Kramer K, Sindhi N, Sarkar P, Upton M, Kalluri R. De-differentiation of primary human hepatocytes depends on the composition of specialized liver basement membrane. Mol Cell Biochem 2006, 283:181-189. 10.1007/s11010-006-2677-8, 16444601.
24. Rabchevsky AG, Weinitz JM, Coulpier M, Fages C, Tinel M, Junier MP. A Role for Transforming Growth Factor alpha as an Inducer of Astrogliosis. J Neurosci 1998, 18:10541-10552.
25. Mosmann T. Rapid coloimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63. 10.1016/0022-1759(83)90303-4, 6606682.
26. Thorndike J, Reif-Lehrer L. A sensitive assay for glutamyltransferase. Enzyme 1971, 12:235-241.
27. Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp J. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 1991, 29:202-209. 10.1002/ana.410290215, 1826418.
28. Heyes MP, Ellis RJ, Ryan L, Childers ME, Grant I, Wolfson T, Archibald S, Jernigan TL. Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. Brain 2001, 124:1033-1042. 10.1093/brain/124.5.1033, 11335705.
29. Heyes MP, Saito K, Lackner A, Wiley CA, Achim CL, Markey SP. Sources of the neurotoxin quinolinic acid in the brain of HIV-1- infected patients and retrovirus-infected macaques. Faseb J 1998, 12:881-896.
30. Kerr SJ, Armati PJ, Brew BJ. Neurocytotoxity of quinolinic acid in human brain cultures. J Neurovirol 1995, 1:375-380. 10.3109/13550289509111027, 9222380.
31. Braidy N, Grant R, Brew BJ, Adams S, Jayasena T, Guillemin GJ. Effects of Kynurenine Pathway Metabolites on Intracellular NAD+ synthesis and Cell Death in Human Primary Astrocytes and Neurons. Int J Trypto Res 2009, 2:61-69.
32. Whetsell WO, Schwarcz R. Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett 1989, 97:271-275. 10.1016/0304-3940(89)90609-5, 2524015.
33. Chen Y, Guillemin GJ. Kynurenine pathway metabolites in humans: Disease and Healthy states. Int J Trypto Res 2009,
34. Halperin JJ, Heyes MP. Neuroactive kynurenines in Lyme borreliosis. Neurology 1992, 42:43-50.
35. Rogove AD, Lu W, Tsirka SE. Microglial activation and recruitment, but not proliferation, suffice to mediate neurodegeneration. Cell Death Differ 2002, 9:801-806. 10.1038/sj.cdd.4401041, 12107823.
36. Shaftel SS, Griffin WS, O'Banion MK. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 2008, 5:7. 10.1186/1742-2094-5-7, 2335091, 18302763.
37. Tuppo EE, Arias HR. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol 2005, 37:289-305. 10.1016/j.biocel.2004.07.009, 15474976.
38. Rogers JT, Leiter LM, McPhee J, Cahill CM, Zhan SS, Potter H, Nilsson LN. Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences. J Biol Chem 1999, 274:6421-6431. 10.1074/jbc.274.10.6421, 10037734.
39. Hogquist KA, Nett MA, Unanue ER, Chaplin DD. Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA 1991, 88:8485-8489. 10.1073/pnas.88.19.8485, 52533, 1924307.
40. Guillemin GJ, Wang L, Brew BJ. Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex. J Neuroinflammation 2005, 2:16. 10.1186/1742-2094-2-16, 1187916, 16042813.
41. Cao L, Fei L, Chang TT, DeLeo JA. Induction of interleukin-1beta by interleukin-4 in lipopolysaccharide-treated mixed glial cultures: microglial-dependent effects. J Neurochem 2007, 102:408-419. 10.1111/j.1471-4159.2007.04588.x, 17442043.
42. Rohl C, Lucius R, Sievers J. The effect of activated microglia on astrogliosis parameters in astrocyte cultures. Brain Res 2007, 1129:43-52. 10.1016/j.brainres.2006.10.057, 17169340.
43. Salinero O, Moreno-Flores MT, Ceballos ML, Wandosell F. beta-Amyloid peptide induced cytoskeletal reorganization in cultured astrocytes. J Neurosci Res 1997, 47:216-223. 10.1002/(SICI)1097-4547(19970115)47:2<216::AID-JNR10>3.0.CO;2-0, 9008152.
44. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434. 10.1002/glia.20207, 15846805.
45. Yamada T, Kawamata T, Walker DG, McGeer PL. Vimentin immunoreactivity in normal and pathological human brain tissue. Acta Neuropathol (Berl) 1992, 84:157-162.
46. Izmailova ES, Snyder SR, Zehner ZE. A Stat1alpha factor regulates the expression of the human vimentin gene by IFN-gamma. J Interferon Cytokine Res 2000, 20:13-20. 10.1089/107999000312694, 10670648.
47. Balasingam V, Tejada-Berges T, Wright E, Bouckova R, Yong VW. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 1994, 14:846-856.
48. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: cellular and molecular cues to biological function [published erratum appears in Trends Neurosci 1998 Feb;21(2):80]. Trends Neurosci 1997, 20:570-577. 10.1016/S0166-2236(97)01139-9, 9416670.
49. Yong VW, Moumdjian R, Yong FP, Ruijs TCG, Freedman MS, Cashman N, Angel JP. g-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci USA 1991, 88:7016-7020. 10.1073/pnas.88.16.7016, 52224, 1908086.
50. Kunkler PE, Kraig RP. Reactive astrocytosis from excitotoxic injury in hippocampal organ culture parallels that seen in vivo. J Cereb Blood Flow Metab 1997, 17:26-43. 10.1097/00004647-199701000-00005, 2695564, 8978384.
51. Castillo-Ruiz MM, Campuzano O, Acarin L, Castellano B, Gonzalez B. Delayed neurodegeneration and early astrogliosis after excitotoxicity to the aged brain. Exp Gerontol 2007, 42:343-354. 10.1016/j.exger.2006.10.008, 17126514.
52. Ribotta MG, Menet V, Privat A. Glial scar and axonal regeneration in the CNS: lessons from GFAP and vimentin transgenic mice. Acta Neurochir Suppl 2004, 89:87-92.
53. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 2004, 5:146-156. 10.1038/nrn1326, 14735117.
54. Eddleston M, Mucke L. Molecular profile of reactive astrocytes--implications for their role in neurologic disease. Neuroscience 1993, 54:15-36. 10.1016/0306-4522(93)90380-X, 8515840.
55. Tejada-Berges T, Yong VW. The astrocyte mitogen, tumor necrosis factor-a, inhibits the proliferative effect of more potent adult human astrocyte mitogens, g-interferon and activated T-lymphocyte supernatants. Brain Research 1994, 653:297-304. 10.1016/0006-8993(94)90404-9, 7982065.
56. Barna BP, Estes ML, Jacobs BS, Hudson S, Ransohoff RM. Human astrocytes proliferate in response to tumor necrosis factor alpha. J Neuroimmunol 1990, 30:239-243. 10.1016/0165-5728(90)90108-Y, 2229411.
57. Guillemin G, Boussin FD, Le Grand R, Croitoru J, Coffigny H, Dormont D. Granulocyte macrophage colony stimulating factor stimulates in vitro proliferation of astrocytes derived from simian mature brains. Glia 1996, 16:71-80. 10.1002/(SICI)1098-1136(199601)16:1<71::AID-GLIA8>3.0.CO;2-E, 8787775.
58. Dihne M, Block F, Korr H, Topper R. Time course of glial proliferation and glial apoptosis following excitotoxic CNS injury. Brain Res 2001, 902:178-189. 10.1016/S0006-8993(01)02378-2, 11384611.
59. Martinez-Contreras A, Huerta M, Lopez-Perez S, Garcia-Estrada J, Luquin S, Beas Zarate C. Astrocytic and microglia cells reactivity induced by neonatal administration of glutamate in cerebral cortex of the adult rats. J Neurosci Res 2002, 67:200-210. 10.1002/jnr.10093, 11782964.
60. Tavares RG, Tasca CI, Santos CE, Wajner M, Souza DO, Dutra-Filho CS. Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain. Neuroreport 2000, 11:249-253. 10.1097/00001756-200002070-00005, 10674464.
61. Lo JC, Huang WC, Chou YC, Tseng CH, Lee WL, Sun SH. Activation of P2X(7) receptors decreases glutamate uptake and glutamine synthetase activity in RBA-2 astrocytes via distinct mechanisms. J Neurochem 2008, 105:151-164. 10.1111/j.1471-4159.2007.05119.x, 18067549.
62. dos Santos AQ, Nardin P, Funchal C, de Almeida LM, Jacques-Silva MC, Wofchuk ST, Goncalves CA, Gottfried C. Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells. Arch Biochem Biophys 2006, 453:161-167. 10.1016/j.abb.2006.06.025, 16904623.
63. Butterfield DA, Hensley K, Cole P, Subramaniam R, Aksenov M, Aksenova M, Bummer PM, Haley BE, Carney JM. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. J Neurochem 1997, 68:2451-2457.
64. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 1995, 65:2146-2156.
65. Rios C, Santamaria A. Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem Res 1991, 16:1139-1143. 10.1007/BF00966592, 1686636.
66. Ting K, Brew BJ, Guillemin GJ. Effect of Quinolinic acid on gene expression in human Astrocytes: Implications for Alzheimer's disease. International Congress Series 2007, 1304.
67. Guillemin G, Meininger V, Brew B. Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis. Neurodegenerative diseases 2006, 2:166-176.